"A semi-rigid tube with nasal prongs designed to be inserted into the nostrils of a patient, and held in place with a headstrap, to administer oxygen (O2). It is commonly known as ""nasal prongs"". This is a single-use device."
| Company | Devices | Share |
|---|---|---|
| Salter Labs | 448 | 34% |
| Medline Industries, Inc. | 94 | 7% |
| Fisher & Paykel Healthcare Limited | 64 | 5% |
| Teleflex Incorporated | 60 | 5% |
| Westmed, Inc. | 54 | 4% |
| Respironics, Inc. | 51 | 4% |
| Dynarex Corporation | 46 | 3% |
| Flexicare Medical Limited | 45 | 3% |
| Vapotherm, Inc. | 44 | 3% |
| Create Biotech Co., Ltd. | 34 | 3% |
| Besmed Health Business Corp. | 34 | 3% |
| Canadian Hospital Specialties Limited | 31 | 2% |
Company = labeler of record on GUDID. 49 companies in total; top 12 shown. Click headers to sort.
Sample of brand names as labelled; no endorsement. Ask us for the full list with company, model and UDI.
| Code | Name | Devices |
|---|---|---|
| CAT | CANNULA, NASAL, OXYGEN | 668 |
| CAT | Cannula, Nasal, Oxygen | 615 |
| BTT | Humidifier, Respiratory Gas, (Direct Patient Interface) | 59 |
| NFB | Conserver, oxygen | 47 |
| BTT | HUMIDIFIER, RESPIRATORY GAS, (DIRECT PATIENT INTERFACE) | 25 |
| MNR | VENTILATORY EFFORT RECORDER | 24 |
Use these as the dimensions to specify in a tender line.
1,316 device records in commercial distribution are listed on the FDA Global Unique Device Identification Database (GUDID) under the GMDN category "Nasal oxygen cannula, basic", from 49 companies. The largest labeler is Salter Labs with 34% of records.
CAT (CANNULA, NASAL, OXYGEN), CAT (Cannula, Nasal, Oxygen), BTT (Humidifier, Respiratory Gas, (Direct Patient Interface)), NFB (Conserver, oxygen)
No. GUDID is the US register. For the UAE (MOHAP/DoH) and Saudi (SFDA/MDMA) a separate registration and a local authorised representative are required; Consulting Wallah can check the status and connect you with registered suppliers.
Add nasal oxygen cannula, basic to the RFQ basket or use the form below with quantity, specification and delivery location; the Network returns comparable quotes from verified suppliers in 2–5 working days.
Hospitals, pharmacies and distributors anywhere: tell us what you need and the Consulting Wallah Network returns comparable quotes from verified suppliers. No fee for buyers.
Source: FDA AccessGUDID (AccessGUDID full release 2 Nov 2026); counts are device records in commercial distribution grouped by GMDN preferred term; companies are labelers of record. Information only — US listing is not a registration in the UAE or GCC; verify with the regulator. © Consulting Wallah — CC BY‑NC‑ND.